New hope for aggressive brain tumors: radioactive drug tested in small trial
Disease control
Completed
This early-stage trial tested a radioactive drug called I-123 ATT001 in 7 adults with recurrent glioblastoma, a fast-growing brain cancer. The drug was given directly into the tumor cavity to see if it was safe and how it spread in the body. The study aimed to find the right dose…
Phase: PHASE1 • Sponsor: Theragnostics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC